9-Arylpurines as a novel class of enterovirus inhibitors

Journal of Medicinal Chemistry

Volumn 53, Issue 1, 2010, Pages 316-324

  Aguado, Leire ^a   Thibaut, Hendrik Jan ^b   Priego, Eva María ^a   Jimeno, María Luisa ^c   Camarasa, María José ^a   Neyts, Johan ^b   Pérez Pérez, María Jesús ^a  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c CSIC Centro de Quimica Organica Lora Tamayo CENQUIOR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2 METHYL 9 [3 (HYDROXYPROP 2 YL)PHENYL]PURINE; 6 CHLORO 9 [3 (HYDROXYMETHYL)PHENYL]PURINE; PURINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; COXSACKIE VIRUS A; COXSACKIE VIRUS B3; DRUG SELECTIVITY; DRUG STRUCTURE; ECHO VIRUS; ENTEROVIRUS; NONHUMAN; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ENTEROVIRUS; HELA CELLS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PURINES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; VERO CELLS;

EID: 74849132742     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm901240p     Document Type: Article

References (38)

1. De Palma, A. M.; Vliegen, I.; De Clercq, E.; Neyts, J. Selective inhibitors of picornavirus replication. Med. Res. Rev. 2008, 28, 823-884.
2. Chen, T. C.; Weng, K. F.; Chang, S. C.; Lin, J. Y.; Huang, P. N.; Shih, S. R. Development of antiviral agents for enteroviruses. J. Antimicrob. Chemother. 2008, 62, 1169-1173.
3. Knowlton, K. U. CVB infection and mechanisms of viral cardiomyopathy. In Group B Coxsackieviruses, 2008; Vol. 323, pp 315-335.
4. Kawai, C. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future. Circulation 1999, 99, 1091-1100.
5. Drescher, K. M.; Tracy, S. M. The CVB and etiology of type 1 diabetes. In Group B Coxsackieviruses; Springer-Verlag: New York, 2008; Vol. 323, pp 259-274.
6. Huber, S.; Ramsingh, A. I. Coxsackievirus-induced pancreatitis. Viral Immunol. 2004, 17, 358-369.
7. Barnard, D. L. Current status of anti-picornavirus therapies. Curr. Pharm. Des. 2006, 12, 1379-1390.
8. 3 antagonist binding. ChemMedChem 2008, 3, 111-119.
9. Casanova, E.; Hernández, A. I.; Priego, E. M.; Liekens, S.; Camarasa, M. J.; Balzarini, J.; Pérez-Pérez, M. J. 5′-O-Tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase. J. Med. Chem. 2006, 49, 5562-5570.
10. 3 adenosine receptor antagonists. J. Med. Chem. 2002, 45, 3337-3344.
11. Chern, J. W.; Lee, H. Y.; Chen, C. S.; Shewach, D. S.; Daddona, P. E.; Townsend, L. B. Nucleosides. 5. Synthesis of guanine and formycin B derivatives as potential inhibitors of purine nucleoside phosphorylase. J. Med. Chem. 1993, 36, 1024-1031.
12. Brakta, M.; Murthy, D.; Ellis, L.; Phadtare, S. 9-[(Hydroxymethyl) phenyl]adenines: new aryladenine substrates of adenosine deaminase. Bioorg. Med. Chem. Lett. 2002, 12, 1489-1492.
13. Ueno, Y.; Kato, T.; Sato, K.; Ito, Y.; Yoshida, M.; Inoue, T.; Shibata, A.; Ebihara, M.; Kitade, Y. Synthesis and properties of nucleic acid analogues consisting of a benzene-phosphate backbone. J. Org. Chem. 2005, 70, 7925-7935.
14. Greenberg, S. M.; Ross, L. O.; Robins, R. K. Potential purine antagonists XXI. Preparation of some 9-phenyl-6-substituted purines. J. Org. Chem. 1959, 24, 1314-1317.
15. Ding, S.; Gray, N. S.; Ding, Q.; Schultz, P. G. Expanding the diversity of purine libraries. Tetrahedron Lett. 2001, 42, 8751-8755.
16. Bakkestuen, A. K.; Gundersen, L. L. Regioselective N-9 arylation of purines employing arylboronic acids in the presence of Cu(II). Tetrahedron Lett. 2003, 44, 3359-3362.
17. Chan, D. M. T.; Monaco, K. L.; Wang, R. P.; Winters, M. P. New N- and O-arylations with phenylboronic acids and cupric acetate. Tetrahedron Lett. 1998, 39, 2933-2936.
18. Lam, P. Y. S.; Clark, C. G.; Saubern, S.; Adams, J.; Winters, M. P.; Chan, D. M. T.; Combs, A. New aryl/heteroaryl C-N bond crosscoupling reactions via arylboronic acid cupric acetate arylation. Tetrahedron Lett. 1998, 39, 2941-2944.
19. Evans, D. A.; Katz, J. L.; West, T. R. Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine. Tetrahedron Lett. 1998, 39, 2937-2940.
20. Huang, H.; Liu, H.; Chen, K. X.; Jiang, H. L. Microwave-assisted rapid synthesis of 2,6,9-substituted purines. J. Comb. Chem. 2007, 9, 197-199.
21. Ueno, Y.; Kawamura, A.; Takasu, K.; Komatsuzaki, S.; Kato, T.; Kuboe, S.; Kitamura, Y.; Kitade, Y. Synthesis and properties of a novel molecular beacon containing a benzene-phosphate backbone at its stem moiety. Org. Biomol. Chem. 2009, 7, 2761-2769.
22. Ley, S. V.; Thomas, A. W. Modern synthetic methods for coppermediated C(aryl)-O, C(aryl)-N, and C(aryl)-S bond formation. Angew. Chem., Int. Ed. 2003, 42, 5400-5449.
23. Huryn, D. M.; Sluboski, B. C.; Tam, S. Y.; Weigele, M.; Sim, I.; Anderson, B. D.; Mitsuya, H.; Broder, S. Synthesis and anti-HIV activity of isonucleosides. J. Med. Chem. 1992, 35, 2347-2354.
24. Harnden, M. R.; Wyatt, P. G.; Boyd, M. R.; Sutton, D. Synthesis and antiviral activity of 9-alkoxypurines. 1. 9-(3-Hydroxypropoxy)-purines and 9-[3-hydroxy-2-(hydroxymethyl)propoxy]purines. J. Med. Chem. 1990, 33, 187-196.
25. Pospisil, P.; Pilger, B. D.; Marveggio, S.; Schelling, P.; Wurth, C.; Scapozza, L.; Folkers, G.; Pongracic, M.; Mintas, M.; Malic, S. R. Synthesis, kinetics, and molecular docking of novel 9-(2-hydroxypropyl) purine nucleoside analogs as ligands of herpesviral thymidine kinases. Helv. Chim. Acta 2002, 85, 3237-3250.
26. Aguado,L.;Camarasa,M. J.; Pérez-Pérez, M. J. Microwave-assisted synthesis of 9-arylpurines. J. Comb. Chem. 2009, 11, 210-212.
27. Wu, Y. J.; He, H.; Sun, L. Q.; Wu, D. D.; Gao, Q.; Li, H. Y. Synthesis of fluorinated 1-(3-morpholin-4-yl-phenyl)-ethylamines. Bioorg. Med. Chem. Lett. 2003, 13, 1725-1728.
28. Tamura, R.; Oda, D.; Kurokawa, H. Synthesis of alpha-amino ketone hydrochlorides via chemoselective hydrogenation of alphanitro ketones. Tetrahedron Lett. 1986, 27, 5759-5762.
29. Kelley, J. L.; Davis, R. G.; McLean, E. W.; Glen, R. C.; Soroko, F. E.; Cooper, B. R. Synthesis and anticonvulsant activity of N-benzylpyrrolo[2, 3-d]pyrimidines, N-benzylpyrazolo[3,4-d]pyrimidines, and N-benzyltriazolo[4,5-d]pyrimidine: imidazole ringmodified analogs of 9-(2-flurobenzyl)-6-(methylamino)-9H-purine. J. Med. Chem. 1995, 38, 3884-3888.
30. Bakkestuen, A. K.; Gundersen, L. L.; Utenova, B. T. Synthesis, biological activity, and SAR of antimycobacterial 9-aryl-, 9-arylsulfonyl-, and 9-benzyl-6-(2-furyl)purines. J. Med. Chem. 2005, 48, 2710-2723.
31. 15N NMR spectroscopy. Nucleic Acids Res. 1991, 19, 1041-1047.
32. Isobe, Y.; Kurimoto, A.; Tobe, M.; Hashimoto, K.; Nakamura, T.; Norimura, K.; Ogita, H.; Takaku, H. Synthesis and biological evaluation of novel 9-substituted-8-hydroxyadenine derivatives as potent interferon inducers. J. Med. Chem. 2006, 49, 2088-2095.
33. Weterings, J. J.; Khan, S.; van Noort, G. J. V.; Melief, C. J. M.; Overkleeft, H. S.; van der Burg, S. H.; Ossendorp, F.; van der Marel, G. A.; Filippov, D. V. 2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation. Bioorg. Med. Chem. Lett. 2009, 19, 2249-2251.
34. De Palma, A. M.; Heggermont, W.; Leyssen, P.; Purstinger, G.; Wimmer, E.; De Clercq, E.; Rao, A.; Monforte, A. M.; Chimirri, A.; Neyts, J. Anti-enterovirus activity and structure-activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a] benzimidazoles. Biochem. Biophys. Res. Commun. 2007, 353, 628-632.
35. Langford, M. P.; Ball, W. A.; Ganley, J. P. Inhibition of the enteroviruses that cause acute hemorrhagic conjunctivitis (Ahc) by benzimidazoles-enviroxime (Ly-122772) and enviradone (Ly-127123). Antiviral Res. 1995, 27, 355-365.
36. Patani, G. A.; La Voie, E. J. Bioisosterism: A rational approach in drug design. Chem. Rev. 1996, 96, 3147-3176.
37. De Palma, A. M.; Heggermont, W.; Lanke, K.; Coutard, B.; Bergmann, M.; Monforte, A. M.; Canard, B.; De Clercq, E.; Chimirri, A.; Purstinger, G.; Rohayem, J.; van Kuppeveld, F.; Neyts, J. The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motifCin the nonstructural protein 2C. J. Virol. 2008, 82, 4720-4730.
38. De Palma, A. M.; Thibaut, H. J.; van der Linden, L.; Lanke, K.; Heggermont, W.; Ireland, S.; Andrews, R.; Arimilli, M.; Al-Tel, T. H.; De Clercq, E.; van Kuppeveld, F.; Neyts, J. Mutations in the Nonstructural Protein 3A Confer Resistance to the Novel Enterovirus Replication Inhibitor TTP-8307. Antimicrob. Agents Chemother. 2009, 53, 1850-1857.